Press Releases (Page 66)
NATIONAL INSTRUMENTS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against National Instruments Corporation and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against National Instruments Corporation (“National Instruments” or the “Company”) (NASDAQ: NATI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired... ❯❯❯
LIVEPERSON ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against LivePerson, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired LivePerson securities between... ❯❯❯
BLUE RIDGE BANKSHARES ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Blue Ridge Bankshares, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Blue Ridge Bankshares, Inc. (“Blue Ridge Bankshares” or the “Company”) (NYSE American: BRBS) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired... ❯❯❯
EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Eagle Pharmaceuticals, Inc. on Behalf of Eagle Pharmaceuticals Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Eagle Pharmaceuticals, Inc. (“Eagle Pharmaceuticals” or the “Company”) (NASDAQ: EGRX) on behalf of Eagle Pharmaceuticals stockholders. Our investigation concerns whether Eagle Pharmaceuticals has violated the federal securities laws and/or engaged in other unlawful... ❯❯❯
INSPIRED ENTERTAINMENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspired Entertainment, Inc. on Behalf of Inspired Entertainment Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspired Entertainment, Inc. (“Inspired Entertainment” or the “Company”) (NASDAQ: INSE) on behalf of Inspired Entertainment stockholders. Our investigation concerns whether Inspired Entertainment has violated the federal securities laws and/or engaged in other unlawful... ❯❯❯
APPLIED MATERIALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Applied Materials, Inc. on Behalf of Applied Materials Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Applied Materials, Inc. (“Applied Materials” or the “Company”) (NASDAQ: AMAT) on behalf of Applied Materials stockholders. Our investigation concerns whether Applied Materials has violated the federal securities laws and/or engaged in other unlawful business practices.... ❯❯❯
DERMTECH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against DermTech, Inc. (“DermTech” or the “Company”) (NASDAQ: DMTK) in the United States District Court for the Southern District of California on behalf of all persons and entities who purchased or otherwise acquired DermTech securities between... ❯❯❯
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation concerns whether Orthofix has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate... ❯❯❯
BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Brainstorm Cell Therapeutics Inc. (“Brainstorm Cell” or the “Company”) (NASDAQ: BCLI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired... ❯❯❯
DOCGO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DocGo, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against DocGo, Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired DocGo securities between November 8,... ❯❯❯
